Vanguard Group’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389M | Buy |
21,363,715
+4,522,266
| +27% | +$82.4M | 0.01% | 1169 |
|
|
2025
Q1 | $334M | Sell |
16,841,449
-1,357,347
| -7% | -$26.9M | 0.01% | 1223 |
|
|
2024
Q4 | $312M | Buy |
18,198,796
+80,302
| +0.4% | +$1.38M | 0.01% | 1314 |
|
|
2024
Q3 | $362M | Buy |
18,118,494
+3,601,842
| +25% | +$72M | 0.01% | 1217 |
|
|
2024
Q2 | $162M | Buy |
14,516,652
+1,827,258
| +14% | +$20.4M | ﹤0.01% | 1607 |
|
|
2024
Q1 | $83.8M | Sell |
12,689,394
-202,481
| -2% | -$1.34M | ﹤0.01% | 1953 |
|
|
2023
Q4 | $58.3M | Buy |
12,891,875
+110,180
| +0.9% | +$498K | ﹤0.01% | 2120 |
|
|
2023
Q3 | $45.8M | Buy |
12,781,695
+336,190
| +3% | +$1.2M | ﹤0.01% | 2174 |
|
|
2023
Q2 | $45.9M | Buy |
12,445,505
+633,878
| +5% | +$2.34M | ﹤0.01% | 2222 |
|
|
2023
Q1 | $39.1M | Buy |
11,811,627
+932,968
| +9% | +$3.09M | ﹤0.01% | 2286 |
|
|
2022
Q4 | $42.2M | Buy |
10,878,659
+1,587,960
| +17% | +$6.16M | ﹤0.01% | 2260 |
|
|
2022
Q3 | $22.6M | Buy |
9,290,699
+250,455
| +3% | +$609K | ﹤0.01% | 2577 |
|
|
2022
Q2 | $17.9M | Buy |
9,040,244
+901,824
| +11% | +$1.79M | ﹤0.01% | 2694 |
|
|
2022
Q1 | $14.9M | Sell |
8,138,420
-345,640
| -4% | -$633K | ﹤0.01% | 2936 |
|
|
2021
Q4 | $12M | Buy |
8,484,060
+2,760,709
| +48% | +$3.89M | ﹤0.01% | 3121 |
|
|
2021
Q3 | $6.47M | Buy |
5,723,351
+114,131
| +2% | +$129K | ﹤0.01% | 3502 |
|
|
2021
Q2 | $8.98M | Buy |
5,609,220
+1,463,105
| +35% | +$2.34M | ﹤0.01% | 3262 |
|
|
2021
Q1 | $7.3M | Buy |
4,146,115
+174,772
| +4% | +$308K | ﹤0.01% | 3332 |
|
|
2020
Q4 | $7.74M | Buy |
3,971,343
+330,608
| +9% | +$645K | ﹤0.01% | 3133 |
|
|
2020
Q3 | $8.7M | Buy |
3,640,735
+127,817
| +4% | +$306K | ﹤0.01% | 2858 |
|
|
2020
Q2 | $10.3M | Sell |
3,512,918
-47,468
| -1% | -$139K | ﹤0.01% | 2758 |
|
|
2020
Q1 | $10.3M | Buy |
3,560,386
+1,247,847
| +54% | +$3.59M | ﹤0.01% | 2610 |
|
|
2019
Q4 | $9.25M | Buy |
2,312,539
+122,495
| +6% | +$490K | ﹤0.01% | 2897 |
|
|
2019
Q3 | $9.75M | Sell |
2,190,044
-258,209
| -11% | -$1.15M | ﹤0.01% | 2827 |
|
|
2019
Q2 | $9.47M | Buy |
2,448,253
+786,567
| +47% | +$3.04M | ﹤0.01% | 2891 |
|
|
2019
Q1 | $6.3M | Buy |
1,661,686
+336,409
| +25% | +$1.28M | ﹤0.01% | 3052 |
|
|
2018
Q4 | $3.17M | Buy |
1,325,277
+132,636
| +11% | +$317K | ﹤0.01% | 3236 |
|
|
2018
Q3 | $7.41M | Buy |
1,192,641
+58,610
| +5% | +$364K | ﹤0.01% | 3071 |
|
|
2018
Q2 | $5.12M | Buy |
1,134,031
+247,044
| +28% | +$1.11M | ﹤0.01% | 3211 |
|
|
2018
Q1 | $4.08M | Buy |
886,987
+247,481
| +39% | +$1.14M | ﹤0.01% | 3228 |
|
|
2017
Q4 | $2.05M | Buy |
639,506
+327,992
| +105% | +$1.05M | ﹤0.01% | 3411 |
|
|
2017
Q3 | $960K | Buy |
311,514
+161,486
| +108% | +$498K | ﹤0.01% | 3600 |
|
|
2017
Q2 | $576K | Hold |
150,028
| – | – | ﹤0.01% | 3701 |
|
|
2017
Q1 | $732K | Buy |
150,028
+4,634
| +3% | +$22.6K | ﹤0.01% | 3662 |
|
|
2016
Q4 | $744K | Buy |
145,394
+8,857
| +6% | +$45.3K | ﹤0.01% | 3647 |
|
|
2016
Q3 | $990K | Buy |
136,537
+15,578
| +13% | +$113K | ﹤0.01% | 3573 |
|
|
2016
Q2 | $720K | Buy |
120,959
+1,000
| +0.8% | +$5.95K | ﹤0.01% | 3695 |
|
|
2016
Q1 | $971K | Buy |
119,959
+93,548
| +354% | +$757K | ﹤0.01% | 3607 |
|
|
2015
Q4 | $214K | Buy |
26,411
+2,376
| +10% | +$19.3K | ﹤0.01% | 4008 |
|
|
2015
Q3 | $201K | Buy |
24,035
+10,265
| +75% | +$85.8K | ﹤0.01% | 4030 |
|
|
2015
Q2 | $128K | Buy |
+13,770
| New | +$128K | ﹤0.01% | 4097 |
|